Enovis Debt to Equity Ratio 2011-2025 | ENOV
Current and historical debt to equity ratio values for Enovis (ENOV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Enovis debt/equity for the three months ending June 30, 2025 was 0.66.
| Enovis Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $2.44B | $2.58B | 0.95 |
| 2025-03-31 | $2.26B | $2.62B | 0.86 |
| 2024-12-31 | $2.15B | $2.56B | 0.84 |
| 2024-09-30 | $2.22B | $3.33B | 0.67 |
| 2024-06-30 | $2.15B | $3.29B | 0.66 |
| 2024-03-31 | $2.17B | $3.31B | 0.66 |
| 2023-12-31 | $1.09B | $3.42B | 0.32 |
| 2023-09-30 | $0.96B | $3.44B | 0.28 |
| 2023-06-30 | $0.99B | $3.45B | 0.29 |
| 2023-03-31 | $0.85B | $3.45B | 0.25 |
| 2022-12-31 | $0.82B | $3.45B | 0.24 |
| 2022-09-30 | $1.04B | $3.41B | 0.30 |
| 2022-06-30 | $1.01B | $3.49B | 0.29 |
| 2022-03-31 | $3.84B | $4.64B | 0.83 |
| 2021-12-31 | $3.85B | $4.66B | 0.83 |
| 2021-09-30 | $3.34B | $4.63B | 0.72 |
| 2021-06-30 | $3.21B | $4.35B | 0.74 |
| 2021-03-31 | $3.78B | $4.29B | 0.88 |
| 2020-12-31 | $3.76B | $3.59B | 1.05 |
| 2020-09-30 | $3.70B | $3.46B | 1.07 |
| 2020-06-30 | $3.73B | $3.40B | 1.10 |
| 2020-03-31 | $4.12B | $3.34B | 1.23 |
| 2019-12-31 | $3.90B | $3.49B | 1.12 |
| 2019-09-30 | $6.46B | $3.13B | 2.06 |
| 2019-06-30 | $6.64B | $3.26B | 2.04 |
| 2019-03-31 | $6.76B | $3.74B | 1.81 |
| 2018-12-31 | $3.14B | $3.48B | 0.90 |
| 2018-09-30 | $2.97B | $3.48B | 0.85 |
| 2018-06-30 | $2.93B | $3.54B | 0.83 |
| 2018-03-31 | $3.04B | $3.84B | 0.79 |
| 2017-12-31 | $2.98B | $3.73B | 0.80 |
| 2017-09-30 | $3.33B | $3.51B | 0.95 |
| 2017-06-30 | $3.36B | $3.37B | 1.00 |
| 2017-03-31 | $3.22B | $3.21B | 1.00 |
| 2016-12-31 | $3.25B | $3.09B | 1.05 |
| 2016-09-30 | $3.37B | $3.17B | 1.07 |
| 2016-06-30 | $3.42B | $3.16B | 1.08 |
| 2016-03-31 | $3.49B | $3.24B | 1.08 |
| 2015-12-31 | $3.48B | $3.26B | 1.07 |
| 2015-09-30 | $3.74B | $3.30B | 1.13 |
| 2015-06-30 | $3.58B | $3.43B | 1.05 |
| 2015-03-31 | $3.70B | $3.25B | 1.14 |
| 2014-12-31 | $3.86B | $3.35B | 1.15 |
| 2014-09-30 | $3.99B | $3.54B | 1.13 |
| 2014-06-30 | $4.28B | $3.65B | 1.17 |
| 2014-03-31 | $3.38B | $3.40B | 0.99 |
| 2013-12-31 | $3.86B | $2.74B | 1.41 |
| 2013-09-30 | $3.76B | $2.57B | 1.47 |
| 2013-06-30 | $3.69B | $2.40B | 1.54 |
| 2013-03-31 | $3.78B | $2.06B | 1.83 |
| 2012-12-31 | $3.99B | $2.16B | 1.85 |
| 2012-09-30 | $3.88B | $2.18B | 1.78 |
| 2012-06-30 | $3.90B | $2.10B | 1.85 |
| 2012-03-31 | $3.91B | $2.22B | 1.76 |
| 2011-12-31 | $0.90B | $0.19B | 4.75 |
| 2011-09-30 | $0.79B | $0.25B | 3.23 |
| 2011-06-30 | $0.81B | $0.25B | 3.18 |
| 2011-03-31 | $0.83B | $0.24B | 3.47 |
| 2010-12-31 | $0.81B | $0.22B | 3.72 |
| 2010-09-30 | $0.78B | $0.23B | 3.44 |
| 2010-06-30 | $0.78B | $0.19B | 4.23 |
| 2010-03-31 | $0.80B | $0.19B | 4.12 |
| 2009-12-31 | $0.79B | $0.22B | 3.64 |
| 2009-09-30 | $0.83B | $0.20B | 4.21 |
| 2009-06-30 | $0.72B | $0.18B | 3.91 |
| 2009-03-31 | $0.72B | $0.17B | 4.27 |
| 2008-12-31 | $0.75B | $0.17B | 4.47 |
| 2008-09-30 | $0.70B | $0.24B | 2.95 |
| 2008-06-30 | $0.71B | $0.23B | 3.04 |
| 2008-03-31 | $0.85B | $0.06B | 13.25 |
| 2007-12-31 | $0.84B | $0.05B | 15.90 |
| 2007-09-30 | $0.00B | 0.00 | |
| 2007-06-30 | $0.00B | 0.00 | |
| 2007-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.765B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |